152 related articles for article (PubMed ID: 31259823)
1. Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
Natarajan E; Auerbach C; Cheron R; Pashankar F
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e659-e661. PubMed ID: 31259823
[TBL] [Abstract][Full Text] [Related]
2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
3. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
[TBL] [Abstract][Full Text] [Related]
4. Novel therapeutic approaches in the treatment of children with hepatoblastoma.
Katzenstein HM; Rigsby C; Shaw PH; Mitchell TL; Haut PR; Kletzel M
J Pediatr Hematol Oncol; 2002 Dec; 24(9):751-5. PubMed ID: 12468918
[TBL] [Abstract][Full Text] [Related]
5. Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11).
Palmer RD; Williams DM
Med Pediatr Oncol; 2003 Jul; 41(1):78-80. PubMed ID: 12764754
[No Abstract] [Full Text] [Related]
6. Addition of Vincristine and Irinotecan to Standard Therapy in a Patient With Refractory High-risk Hepatoblastoma Achieving Long-term Relapse-free Survival.
Powers JM; Pacheco MM; Wickiser JE
J Pediatr Hematol Oncol; 2019 Apr; 41(3):e171-e173. PubMed ID: 29668545
[TBL] [Abstract][Full Text] [Related]
7. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
von Schweinitz D; Byrd DJ; Hecker H; Weinel P; Bode U; Bürger D; Erttmann R; Harms D; Mildenberger H
Eur J Cancer; 1997 Jul; 33(8):1243-9. PubMed ID: 9301450
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
Zsíros J; Brugières L; Brock P; Roebuck D; Maibach R; Child M; Morland B; Casanova M; Pariente D; Paris C; de Camargo B; Ronghe M; Zimmermann A; Plaschkes J; Czauderna P; Perilongo G
Eur J Cancer; 2012 Dec; 48(18):3456-64. PubMed ID: 22835780
[TBL] [Abstract][Full Text] [Related]
9. Irinotecan as maintenance therapy in high-risk hepatoblastoma.
Qayed M; Powell C; Morgan ER; Haugen M; Katzenstein HM
Pediatr Blood Cancer; 2010 May; 54(5):761-3. PubMed ID: 20063426
[TBL] [Abstract][Full Text] [Related]
10. Response of heavily treated and relapsed hepatoblastoma in the transplanted liver to single-agent therapy with irinotecan.
Ijichi O; Ishikawa S; Shinkoda Y; Tanabe T; Okamoto Y; Takamatsu H; Inomata Y; Kawano Y
Pediatr Transplant; 2006 Aug; 10(5):635-8. PubMed ID: 16857004
[TBL] [Abstract][Full Text] [Related]
11. High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
Häberle B; Maxwell R; Schweinitz DV; Schmid I
Klin Padiatr; 2019 Nov; 231(6):283-290. PubMed ID: 31645068
[TBL] [Abstract][Full Text] [Related]
12. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
Fuchs J; Wenderoth M; von Schweinitz D; Haindl J; Leuschner I
Cancer; 1998 Dec; 83(11):2400-7. PubMed ID: 9840541
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
O'Neill AF; Towbin AJ; Krailo MD; Xia C; Gao Y; McCarville MB; Meyers RL; McGahren ED; Tiao GM; Dunn SP; Langham MR; Weldon CB; Finegold MJ; Ranganathan S; Furman WL; Malogolowkin M; Rodriguez-Galindo C; Katzenstein HM
J Clin Oncol; 2017 Oct; 35(30):3465-3473. PubMed ID: 28892430
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report.
Abu-Ghosh AM; Krailo MD; Goldman SC; Slack RS; Davenport V; Morris E; Laver JH; Reaman GH; Cairo MS
Ann Oncol; 2002 Mar; 13(3):460-9. PubMed ID: 11996479
[TBL] [Abstract][Full Text] [Related]
15. Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol.
Sarper N; Corapçioğlu F; Anik Y; Ural D; Yildiz K; Tugay M
J Pediatr Hematol Oncol; 2006 Jun; 28(6):386-90. PubMed ID: 16794509
[TBL] [Abstract][Full Text] [Related]
16. Individualized chemotherapy and efficacy analysis of hepatoblastoma in children.
Hu H; Zhang W; Zhang Y; Gao Y; Zhi T; Li F; Li J; Gu H; Liao R; Wu R; Huang D
Pediatr Blood Cancer; 2024 Jan; 71(1):e30693. PubMed ID: 37937320
[TBL] [Abstract][Full Text] [Related]
17. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
Katzenstein HM; London WB; Douglass EC; Reynolds M; Plaschkes J; Finegold MJ; Bowman LC
J Clin Oncol; 2002 Aug; 20(16):3438-44. PubMed ID: 12177104
[TBL] [Abstract][Full Text] [Related]
18. [Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
Pan C; Tang JY; Chen J; Xue HL; Dong L; Zhou M; Jiang H; Ye QD; Gu LJ
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):659-62. PubMed ID: 19695195
[TBL] [Abstract][Full Text] [Related]
19. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
[TBL] [Abstract][Full Text] [Related]
20. Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
Hishiki T; Matsunaga T; Sasaki F; Yano M; Ida K; Horie H; Kondo S; Watanabe K; Oue T; Tajiri T; Kamimatsuse A; Ohnuma N; Hiyama E
Pediatr Surg Int; 2011 Jan; 27(1):1-8. PubMed ID: 20922397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
